Wire · opportunities
Abbott initiates VOYAGER clinical trial for investigational Encantor™ software-guided ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 19 November 2026 · Fusion42 review
Abbott has launched the VOYAGER clinical trial to evaluate the Encantor™ software-guided balloon-expandable transcatheter aortic valve implantation (TAVI) system for treating aortic stenosis.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 19 Nov 2026 and 20 Nov 2026.
◆ ◆ The Wire takeaway
You can now explore software-guided TAVI platforms as a new frontier in heart valve therapy, opening routes for innovation in minimally invasive cardiology devices. This signalling trial highlights where clinical differentiation can unlock greater adoption and regulatory support.
◆ Coverage
3 sources · first reported 19 Nov 2026 · latest 20 Nov 2026
◆ Related on Wire
◆ Topics